Merck Announces Organon & Co. as New Company Name for …
Mar 11, 2020 · Organon has been an important part of Merck since the 2009 Schering-Plough acquisition. The Organon name has strong brand equity and engenders great respect among health care professionals for its dedication and innovation in women’s health.
Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Merck Announces New Name for its Animal Health Division
Jun 29, 2011 · Intervet/Schering-Plough Animal Health, announced that effective today it will begin using the new name, Merck Animal Health. It will be known as MSD Animal Health outside the United States and Canada. “The name change reflects Merck’s commitment to animal health and its complementary role to the overall business,” said Raul Kohan, President
History - Merck.com
Merck and Schering-Plough completed a merger and began combined operations. The purchase made the company the second largest pharmaceutical company in United States by revenue.
Merck and sanofi-aventis to Maintain Separate Businesses in …
Mar 22, 2011 · Merck and sanofi-aventis mutually determined that ending their plan is in the best interests of both companies and their respective shareholders, as well as the employees of Merial and Intervet/Schering Plough.
Who we are - Merck.com
Merck is a research-intensive biopharmaceutical company committed to saving and improving lives through science.
What can we help you find? - Merck
Apr 15, 2011 · Under the terms of the amended distribution agreement, Merck’s subsidiary, Schering-Plough (Ireland) will relinquish exclusive marketing rights for REMICADE and SIMPONI to Johnson & Johnson’s Janssen pharmaceutical companies in territories including Canada, Central and South America, the Middle East, Africa and Asia Pacific ...
Early Conversion of the Schering-Plough Preferred Stock Upon a Make-Whole Acquisition This summary describes certain material U.S. federal income tax consequences of the conversion of the 6.00% mandatory convertible preferred stock of Schering-Plough (the “Schering-Plough preferred stock”)
SEC filings - Merck.com
Jan 3, 2025 · Review Merck & Co.’s financial catalog of past SEC filings and SEC certifications.
Contact us - Merck.com
Our corporate headquarters is located at: 126 East Lincoln Avenue P.O. Box 2000 Rahway, NJ 07065 USA. To reach a Merck employee, please call: 1-908-740-4000